The Obama administration can continue to fund research that uses human embryonic stem cells, a federal appeals court ruled this morning. The decision overturns a lower court ban on the practice and provides certainty -- at least for now -- for scientists who had been left in limbo.
Scientists and patient advocacy groups have been caught in a frustrating round of legal ping-pong since last August, when a federal judge halted federal funding for such research. In September, the appeals court lifted the ban temporarily, while it decided the broader merits of the case.
Today, the appeals court decided to permanently lift the ban for the promising field of research, which offers hope for the treatment of everything from spinal cord injury to diabetes .
About white coat notes
|White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at email@example.com. Follow her on Twitter: @cconaboy.|
Gideon Gil, Health and Science Editor
Elizabeth Comeau, Senior Health Producer